GAMMA Investing »

Taysha Gene Therapies shares owned by GAMMA Investing

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5k 276 5.50

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)

View all positions for GAMMA Investing

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings
Geode Capital Management

View all funds holding Taysha Gene Therapies